The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cellular Goods launch luxury festive gift sets

5 Dec 2023 07:00

RNS Number : 6384V
Cellular Goods PLC
05 December 2023
 

05 December 2023

 

Cellular Goods plc

 

("Cellular Goods" or "The Company")

 

Cellular Goods launch luxury gift sets for the festive season

 

Cellular Goods (LSE: CBX), a UK based company pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions, is pleased to announce the launch of its 'Look Better' skincare range festive gift sets for the Christmas season.

 

The 'Gift Better' collection comprises the Nourish and Relax Gift Set, containing Cellular Goods' Cannabinoid Face Oil, a camomile and lavender scented candle, a luxury silk sleeping eye mask and a vegan leather reusable bag. Also available for purchase is the Rejuvenate and Indulge Gift Set, containing Cellular Goods' Cannabinoid Face Serum and the Rejuvenating Night Cream, a camomile and lavender scented candle, a luxury silk sleeping eye mask and a vegan leather reusable vanity bag.

 

The 'Gift Better' range adds festive gifting options to the Company's gift set repertoire that already includes the Rejuvenate and Unwind, and Calm and Balance Gift Sets. All gift sets are available for purchase on the Company's ecommerce site www.cellular-goods.com.

 

Darcy Taylor, Interim CEO at Cellular Goods, commented: "Cellular Goods is pleased to announce the launch of our 'Gift Better' collection, featuring two premium gift sets tailored for the festive season. Both gift sets include skincare products powered by our breakthrough anti-inflammatory CBG, that soothes and protects the skin from irritation, redness, blemishes, and aging. With shipping now available to the UK, US, and nine EU regions, we are well positioned to meet the rising demand during this peak festive period for convenient and luxurious gifting options. This festive range allows us to introduce premium-quality skincare and wellness products containing lab-produced cannabinoids to a broader audience at attractive price points."

 

For further information please contact:

 

Cellular Goods

Darcy Taylor

Chairman and Interim CEO

via FSCF +44 7572 873 300

First Sentinel Corporate Finance (FSCF)

Investor Relations

Rebecca Noonan

IR@cellular-goods.com

Media Relations

Rebecca Noonan

Media@cellular-goods.com

Corporate Broker & Advisor

Brian Stockbridge

 

+44 7572 873 300

 

 

+44 7572 873 300

 

 

+44 7876 888 011

Novum Securities

 

Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427 

 

About Cellular Goods PLC:

Cellular Goods is pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions. The Company launched with a focus on efficacy led and science-backed products utilising biosynthetics, and now employs its expertise across two verticals: premium next-generation cannabinoid skincare products, and carbon sequestration-as-a-service through its wholly owned business division, King Tide Carbon, which utilises biosynthetic algae and seaweed to provide scalable carbon removal.

 

The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.cellular-goods.com.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFFFIIFFLSIIV
Date   Source Headline
23rd Dec 20227:00 amRNSTR-1: Standard notification of major holdings
23rd Dec 20227:00 amRNSCellular Goods Annual Results
23rd Nov 20226:16 pmRNSTR-1: Standard notification of major holdings
2nd Nov 202210:34 amRNSTR-1: Standard notification of major holdings
24th Oct 20227:00 amRNSProducts launch on Debenhams.com
20th Oct 20227:00 amRNSLaunch of gift set collection for festive season
26th Sep 20227:00 amRNSProposed purchase of Cannaray Brands and Love CBD
23rd Sep 20225:49 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20225:47 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20225:42 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20227:00 amRNSCellular Goods now shipping products to the USA
23rd Sep 20227:00 amRNSCellular Goods now shipping products to the USA
21st Sep 20222:06 pmRNSSecond Price Monitoring Extn
21st Sep 20222:00 pmRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSLaunch of three new skincare products
6th Sep 20227:00 amRNSPublication of new white paper
17th Aug 20227:00 amRNSGrant of Share Options
16th Aug 20227:00 amRNSAppointment of new Chief Financial Officer
5th Aug 20224:40 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
4th Aug 20229:05 amRNSSecond Price Monitoring Extn
4th Aug 20229:00 amRNSPrice Monitoring Extension
3rd Aug 20224:41 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20229:05 amRNSSecond Price Monitoring Extn
3rd Aug 20229:00 amRNSPrice Monitoring Extension
2nd Aug 20224:40 pmRNSSecond Price Monitoring Extn
2nd Aug 20224:35 pmRNSPrice Monitoring Extension
2nd Aug 202211:05 amRNSSecond Price Monitoring Extn
2nd Aug 202211:00 amRNSPrice Monitoring Extension
1st Aug 20222:00 pmRNSPrice Monitoring Extension
13th Jul 20227:00 amRNSUpdate on marketing initiatives and YouGov survey
11th Jul 20227:00 amRNSLaunch of minis
20th Jun 20227:00 amRNSLaunch of CBG and CBD petition
30th May 20227:00 amRNSInterim results
20th May 20227:00 amRNSTR-1: Standard notification of major holdings
20th May 20227:00 amRNSTR-1: Standard notification of major holdings
16th May 20222:05 pmRNSSecond Price Monitoring Extn
16th May 20222:00 pmRNSPrice Monitoring Extension
12th May 20227:00 amRNSBoard changes
28th Apr 20227:00 amRNSInvestor presentation
28th Apr 20227:00 amRNSFirst patent application filed
22nd Apr 20226:04 pmRNSUpdate on ingestibles product range
22nd Apr 20227:00 amRNSWhite paper on lab-produced cannabinoids
13th Apr 20227:00 amRNSUpdate on ingestibles product range
11th Apr 20227:00 amRNSUpdate on ingestibles products
7th Apr 202210:24 amRNSTR-1: Standard notification of major holdings
1st Apr 20222:05 pmRNSSecond Price Monitoring Extn
1st Apr 20222:00 pmRNSPrice Monitoring Extension
28th Mar 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.